What are the opening hours?

Monday 9am - 5pm Tuesday 9am - 5pm Wednesday 9am - 5pm Thursday 9am - 5pm Friday 9am - 5pm

Harlem Prevention Center

Home
United States
New York, NY
Harlem Prevention Center

Contact information, map and directions, contact form, opening hours, services, ratings, photos, videos and announcements from Harlem Prevention Center, AIDS Resource Center, 215 West 125th Street, 3rd Floor, Suite 302, New York, NY.

Conducting research in the Harlem community for more than 10 years, our mission is to advance research in HIV prevention, care and treatment; with focus on underrepresented and medically under-served communities in New York City.

03/26/2025

PrEP is for everyone. PrEP is for women. To learn more about PrEP, call/ text 917-841-4125.

02/04/2025

PrEP is for women too! Call / text 917-841-4125 to learn more.

ICAP

Address

215 West 125th Street, 3rd Floor, Suite 302
New York, NY
10027

Opening Hours

Monday	9am - 5pm
Tuesday	9am - 5pm
Wednesday	9am - 5pm
Thursday	9am - 5pm
Friday	9am - 5pm

Website

https://linktr.ee/hpcharlem

Alerts

Be the first to know and let us send you an email when Harlem Prevention Center posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Harlem Prevention Center:

Featured

Magnus Wellness
16 E 40th Street, Fl 4

Want your practice to be the top-listed Clinic in New York?

Our Story

Harlem Prevention Center was launched in 2009 as an HIV Prevention Trials Network (HPTN) clinical research site within ICAP’s Centers for Innovative Research to Control AIDS (CIRCA) Clinical Trials Unit, with a mission to advance research in HIV prevention, care and treatment, with focus on underrepresented and medically underserved communities in New York City.

Currently, the site is one of the 4 clinical research sites within the Columbia Partnership for Prevention and Control of HIV/AIDS Clinical Trials Unit under the leadership of Drs. Wafaa El-Sadr and Magdalena Sobieszczyk as co-Principal Investigators. Dr. El-Sadr is also the founder and global director of ICAP at Columbia University Mailman School of Public Health.

The site is in the heart of Harlem on 125th Street, the main thoroughfare in Central Harlem. The site’s central location, with proximity to multiple forms of public transportation, has facilitated the recruitment and retention of study participants. The site is equipped with a Clinical Laboratory Improvement Amendments (CLIA) certified lab, (2) -80-degree freezer for specimen storage, a biomedical refrigerator for study drug storage, a fully equipped intravenous infusion therapy room, clinician’s exam room, interview rooms, as well as Computer Assisted Self Interview (CASI) stations for online surveys.

Since its launching in 2009, the site has enrolled a total 2,861 study participants that included women, MSM and TGW populations. The site has successfully participated in the following HPTN studies: HPTN 061 (The BROTHERS Study), a multi-site acceptability and feasibility study of HIV and STI testing, HIV risk reduction counseling, condom distribution, and peer navigation for HIV risk reduction; HPTN 064 (ISIS Study), was a venue–based recruitment in neighborhoods with high rates of HIV and poverty conducted in six US cities; HPTN 067 (ADAPT Study) where Harlem Prevention Center was the only US site chosen to implement this Pre-Exposure Prophylaxis (PrEP) trial, investigating the feasibility and acceptability of alternative PrEP dosing with 3 distinct populations in Bangkok , Cape Town and Harlem (New York). The site has completed enrollment of its current HPTN studies, and is currently following up study participants in HVTN 704/HPTN 085 (AMP study), a five year study testing the safety, tolerability, and prevention benefit of a manufactured broadly neutralizing antibody (known as VRC01) against HIV, and HPTN 083, an HIV prevention study testing the safety and efficacy of the injectable agent, cabotegravir, for pre-exposure prophylaxis (PrEP) in HIV uninfected men and transgender women (TGW) who have s*x with men.

The site was also named as one of the four sites to participate in the upcoming HVTN 130/HPTN 089, a phase 1 study testing the safety, tolerability, and functional activity of a combination of monoclonal antibodies in healthy, HIV uninfected adult participants.

Aside from HPTN studies, the site also completed two investigator-initiated studies funded by the National Institute on Drug Abuse (NIDA) and the National Institute of Mental Health (NIMH). These studies include the STAR Study (Seek, Test and Retain), a five-year study testing the effectiveness of respondent-driven sampling to seek and recruit substance-using black men who have s*x with men (MSM) at high risk for HIV, as well as a comparison of two methods to promote linkage and retention in HIV primary care for those identified as HIV-infected; and the PrEPared and Strong Study, also a five-year, multi-method implementation study that tests an enhanced PrEP adherence package against a standard package in a randomized clinical trial located in a community setting.

Based on its strong recruitment and retention of black women and black MSM in HPTN studies, the Harlem Prevention Center was given the HPTN Community Award for Excellence for Best Accrual in 2010.

The site’s successes are also a testament to its well-experienced and diverse staff. The site has retained key staff members with extensive relevant experience working with MSM and transgender women populations in the oversight, recruitment, retention, and day-to-day conduct of HIV prevention research since 2009. Key staff members previously worked at Harlem Hospital Division of Infectious Diseases under then chief Dr. Wafaa El-Sadr, conducting multiple community-based research studies on HIV/AIDS across DAIDS networks including HPTN.

The site is led by Dr. Sharon Mannheimer, who is currently the Chief of Infectious Diseases at Harlem Hospital, Assistant Dean, Student Affairs at Columbia University Affiliation at Harlem Hospital and Associate Professor of Clinical Medicine (in Epidemiology) at Columbia University’s College of Physicians and Surgeons and Columbia’s Mailman School of Public Health.